Expression of cytokeratin 20 redefines urothelial papillomas of the bladder
- 1 March 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9157) , 974-977
- https://doi.org/10.1016/s0140-6736(98)05383-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cytokeratin 20 as an objective marker of urothelial dysplasiaBritish Journal of Urology, 1996
- Transitional cell carcinoma of the bladder: diagnosis and prognosisCurrent Diagnostic Pathology, 1996
- Factors affecting recurrence and progression in superficial bladder tumoursEuropean Journal Of Cancer, 1995
- Cytokeratin 20 expression by non‐invasive transitional cell carcinomas: potential for distinguishing recurrent from non‐recurrent diseaseHistopathology, 1995
- The application of a prognostic factor analysis for Ta.T1 bladder Cancer in routine urological practiceBritish Journal of Urology, 1995
- Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975–1989European Journal Of Cancer, 1994
- Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapyBMJ, 1994
- Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?Cancer, 1987
- Benign Papilloma or Papillary Carcinoma of the Bladder?Journal of Urology, 1973
- The Biological Behavior of Transitional Cell Papilloma of the BladderJournal of Urology, 1950